by Jenn Porter | Dec 13, 2018 | OTC Drugs
What is Pharmacovigilance? Pharmacovigilance is defined by the World Health Organization as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem”. In simpler terms,...
by Jenn Porter | Dec 5, 2018 | Canadian Regulatory, Natural Health Products, OTC Drugs
When developing a product that requires market authorization, either by way of a DIN (drug identification number) or an NPN (natural product number), product monographs are essential documents provided by Health Canada that layout mandatory label information. These...
by Jenn Porter | Nov 28, 2018 | Canadian Regulatory, Natural Health Products
The cousin of the cannabinoid family that sits alone in the corner, cannabidiol (CBD) is a relatively silent member in the recreational cannabis legalization family. The non-psychoactive counterpart to THC, this compound had a much lower profile until recently. Before...
by Jenn Porter | Nov 21, 2018 | Cosmetics, U.S. Regulatory
Anywhere you go its hard to not come across some form of cosmetic product. Imagine yourself as a consumer looking to purchase a tube of red lipstick. There are more than a dozen brands capable of providing you with a vast selection for such a simple request. With a...
by Jenn Porter | Nov 7, 2018 | Cosmetics, Research/Science/Technology
1. Cannabis Usage Trends With growing global leniency on this once highly regulated and stigmatized substance, a change in perspective is having a profound effect on its use in cosmetics and other forms of personal care. Big companies like Estee Lauder are starting to...
Recent Comments